SynthesisImmunotherapy2026

Efficacy of first-line immune checkpoint inhibitors for recurrent/metastatic head and neck cancer: a systematic review and meta-analysis.

Jiuli Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.